4 research outputs found
Efficacy of lorlatinib in lung carcinomas carrying distinct ALK translocation variants: The results of a single-center study
Background: Lorlatinib is a novel potent ALK inhibitor, with only a few studies reporting the results of its clinical use. Methods: This study describes the outcomes of lorlatinib treatment for 35 non-small cell lung cancer patients with ALK rearrangements, who had 2 (nΒ =Β 5), 1 (nΒ =Β 26) or none (nΒ =Β 4) prior tyrosine kinase inhibitors and received lorlatinib mainly within the compassionate use program. Results: Objective tumor response (OR) and disease control (DC) were registered in 15/35 (43%) and 33/35 (94%) patients, respectively; brain metastases were particularly responsive to the treatment (OR: 22/27 (81%); DC: 27/27 (100%)). Median progression free survival (PFS) was estimated to be 21.8 months, and median overall survival (OS) approached to 70.1 months. Only 4 out of 35 patients experienced no adverse effects; two of them were the only subjects who had no clinical benefit from lorlatinib. PFS and OS in the no-adverse-events lorlatinib users were strikingly lower as compared to the remaining patients (1.1 months vs. 23.7 months and 10.5 months vs. not reached, respectively; p < 0.0001 for both comparisons). ALK translocation variants were known for 28 patients; there was no statistical difference between patients with V.1 and V.3 rearrangements with regard to the OS or PFS. Conclusion: Use of lorlatinib results in excellent disease outcomes, however caution must be taken for patients experiencing no adverse effects from this drug
ΠΠΎΠΌΠΏΠ»Π΅ΠΌΠ΅Π½ΡΠ°ΡΠ½Π°Ρ ΠΌΠΎΠ΄Π΅Π»Ρ ΡΠ°ΠΌΠΎΠ΄Π΅ΡΠ΅ΡΠΌΠΈΠ½Π°ΡΠΈΠΈ Π»ΠΈΡΠ½ΠΎΡΡΠΈ
Introduction. The relevance of studying the phenomenon of self-determination is substantiatedby the compliance of this research problem with two actively developing areas of personalitypsychology β the psychology of a change and the psychology of a possible. The variety ofmanifestations of personality self-determination, the complexity and uniqueness of this phenomenonnecessitate the generalization of existing theoretical developments, ideas and concepts, as wellas accumulated empirical material. Modern Russian authors formulate theoretical prerequisitesfor the study of self-determination in the framework of the subject-activity approach, however,providing empirical research, they are often based on the methodology of foreign colleagues.The originality of the present work consists in the search for new methodological foundations forthe study of personality self-determination. Theoretical justification. The complexity and ambiguityof the phenomenon of self-determination enhance the differentiation of theoretical approachesto its description. The researchers focus on different levels of manifestations of self-determination:the nature-conditioned ability to self-organization and the innate need for autonomy of theindividuum, the processes of self-regulation of behavior and activity by the Subject, the mechanismsof the formation of subjectity and the development of the Self, as well as personalityβs ways torealize a freedom and an intentionality. Along with a wide variety of theories and concepts,there is a deficiency of systemic and complex models. Results. The authors of the article firstproposed the complementary model of self-determination, which allows to integrate existingtheoretical approaches to research through a level-by-level consideration of individβs, subjectβsand personality characteristics. The basic level of spontaneous (functional) self-determinationcorresponds to the principles of self-organization of complex open non-equilibrium systems witha naturally conditioned ability to self-deterministic behavior. The second level of purposeful orβactivity-basedβ self-determination demonstrates the role of conscious planning, volitional effortand conscious choice as a tool for achieving goals and self-regulation of the Subject. Finally, thethird, highest level of meaningful self-determination describes the value and moral self-regulationassociated with the implementation of meaningful choices. Discussion. The research presents anew look at the scientific problem of personality self-determination. The complementary modelreflects a complex multilevel system of self-determination, the evolution of its mechanisms in the process of ontogenesis from the basic psychological needs of the individuum to the complexprocesses of meaningful self-determination of the personality.ΠΠ²Π΅Π΄Π΅Π½ΠΈΠ΅. ΠΠΊΡΡΠ°Π»ΡΠ½ΠΎΡΡΡ ΠΈΠ·ΡΡΠ΅Π½ΠΈΡ ΡΠ΅Π½ΠΎΠΌΠ΅Π½Π° ΡΠ°ΠΌΠΎΠ΄Π΅ΡΠ΅ΡΠΌΠΈΠ½Π°ΡΠΈΠΈ ΠΎΠΏΡΠ΅Π΄Π΅Π»ΡΠ΅ΡΡΡ ΡΠΎΠΎΡΠ²Π΅ΡΡΡΠ²ΠΈΠ΅ΠΌ Π΄Π°Π½Π½ΠΎΠΉ ΠΈΡΡΠ»Π΅Π΄ΠΎΠ²Π°ΡΠ΅Π»ΡΡΠΊΠΎΠΉ ΠΏΡΠΎΠ±Π»Π΅ΠΌΠ°ΡΠΈΠΊΠΈ ΡΡΠ°Π·Ρ Π΄Π²ΡΠΌ Π°ΠΊΡΠΈΠ²Π½ΠΎ ΡΠ°Π·Π²ΠΈΠ²Π°ΡΡΠΈΠΌΡΡ Π½Π°ΠΏΡΠ°Π²Π»Π΅Π½ΠΈΡΠΌ ΠΏΡΠΈΡ
ΠΎΠ»ΠΎΠ³ΠΈΠΈ Π»ΠΈΡΠ½ΠΎΡΡΠΈ β ΠΏΡΠΈΡ
ΠΎΠ»ΠΎΠ³ΠΈΠΈ ΠΈΠ·ΠΌΠ΅Π½Π΅Π½ΠΈΠΈΜ ΠΈ ΠΏΡΠΈΡ
ΠΎΠ»ΠΎΠ³ΠΈΠΈ Π²ΠΎΠ·ΠΌΠΎΠΆΠ½ΠΎΠ³ΠΎ. ΠΠ½ΠΎΠ³ΠΎΠΎΠ±ΡΠ°Π·ΠΈΠ΅ ΠΏΡΠΎΡΠ²Π»Π΅Π½ΠΈΠΉ ΡΠ°ΠΌΠΎΠ΄Π΅ΡΠ΅ΡΠΌΠΈΠ½Π°ΡΠΈΠΈ Π»ΠΈΡΠ½ΠΎΡΡΠΈ, ΡΠ»ΠΎΠΆΠ½ΠΎΡΡΡ ΠΈ ΡΠ½ΠΈΠΊΠ°Π»ΡΠ½ΠΎΡΡΡ ΡΡΠΎΠ³ΠΎ ΡΠ΅Π½ΠΎΠΌΠ΅Π½Π° ΠΎΠ±ΡΡΠ»Π°Π²Π»ΠΈΠ²Π°ΡΡ Π½Π΅ΠΎΠ±Ρ
ΠΎΠ΄ΠΈΠΌΠΎΡΡΡ ΠΎΠ±ΠΎΠ±ΡΠ΅Π½ΠΈΡ ΠΈΠΌΠ΅ΡΡΠΈΡ
ΡΡ ΡΠ΅ΠΎΡΠ΅ΡΠΈΡΠ΅ΡΠΊΠΈΡ
ΡΠ°Π·ΡΠ°Π±ΠΎΡΠΎΠΊ, ΠΈΠ΄Π΅ΠΉ ΠΈ ΠΊΠΎΠ½ΡΠ΅ΠΏΡΠΈΠΉ, Π° ΡΠ°ΠΊΠΆΠ΅ Π½Π°ΠΊΠΎΠΏΠ»Π΅Π½Π½ΠΎΠ³ΠΎ ΡΠΌΠΏΠΈΡΠΈΡΠ΅ΡΠΊΠΎΠ³ΠΎ ΠΌΠ°ΡΠ΅ΡΠΈΠ°Π»Π°. Π‘ΠΎΠ²ΡΠ΅ΠΌΠ΅Π½Π½ΡΠ΅ ΠΎΡΠ΅ΡΠ΅ΡΡΠ²Π΅Π½Π½ΡΠ΅ Π°Π²ΡΠΎΡΡ ΡΠΎΡΠΌΡΠ»ΠΈΡΡΡΡ ΡΠ΅ΠΎΡΠ΅ΡΠΈΡΠ΅ΡΠΊΠΈΠ΅ ΠΏΡΠ΅Π΄ΠΏΠΎΡΡΠ»ΠΊΠΈ ΠΈΠ·ΡΡΠ΅Π½ΠΈΡ ΡΠ°ΠΌΠΎΠ΄Π΅ΡΠ΅ΡΠΌΠΈΠ½Π°ΡΠΈΠΈ Π² ΡΡΡΠ»Π΅ ΡΡΠ±ΡΠ΅ΠΊΡΠ½ΠΎ-Π΄Π΅ΡΡΠ΅Π»ΡΠ½ΠΎΡΡΠ½ΠΎΠ³ΠΎ ΠΏΠΎΠ΄Ρ
ΠΎΠ΄Π°, Π½ΠΎ ΠΏΡΠΈ ΡΡΠΎΠΌ ΡΠ°ΡΡΠΎ Π·Π°ΠΈΠΌΡΡΠ²ΡΡΡ ΠΌΠ΅ΡΠΎΠ΄ΠΎΠ»ΠΎΠ³ΠΈΡ ΠΈΡΡΠ»Π΅Π΄ΠΎΠ²Π°Π½ΠΈΡ Ρ Π·Π°ΡΡΠ±Π΅ΠΆΠ½ΡΡ
ΠΊΠΎΠ»Π»Π΅Π³. ΠΡΠΈΠ³ΠΈΠ½Π°Π»ΡΠ½ΠΎΡΡΡ Π΄Π°Π½Π½ΠΎΠΉ ΡΠ°Π±ΠΎΡΡ Π·Π°ΠΊΠ»ΡΡΠ°Π΅ΡΡΡ Π² ΠΏΠΎΠΈΡΠΊΠ΅ Π½ΠΎΠ²ΡΡ
ΠΌΠ΅ΡΠΎΠ΄ΠΎΠ»ΠΎΠ³ΠΈΡΠ΅ΡΠΊΠΈΡ
ΠΎΡΠ½ΠΎΠ²Π°Π½ΠΈΠΉ ΠΈΡΡΠ»Π΅Π΄ΠΎΠ²Π°Π½ΠΈΡ ΡΠ°ΠΌΠΎΠ΄Π΅ΡΠ΅ΡΠΌΠΈΠ½Π°ΡΠΈΠΈ Π»ΠΈΡΠ½ΠΎΡΡΠΈ. Π’Π΅ΠΎΡΠ΅ΡΠΈΡΠ΅ΡΠΊΠΎΠ΅ ΠΎΠ±ΠΎΡΠ½ΠΎΠ²Π°Π½ΠΈΠ΅. Π‘Π»ΠΎΠΆΠ½ΠΎΡΡΡ ΠΈ Π½Π΅ΠΎΠ΄Π½ΠΎΠ·Π½Π°ΡΠ½ΠΎΡΡΡ ΡΠ΅Π½ΠΎΠΌΠ΅Π½Π° ΡΠ°ΠΌΠΎΠ΄Π΅ΡΠ΅ΡΠΌΠΈΠ½Π°ΡΠΈΠΈ ΡΡΠΈΠ»ΠΈΠ²Π°Π΅Ρ Π΄ΠΈΡΡΠ΅ΡΠ΅Π½ΡΠΈΠ°ΡΠΈΡ ΡΠ΅ΠΎΡΠ΅ΡΠΈΡΠ΅ΡΠΊΠΈΡ
ΠΏΠΎΠ΄Ρ
ΠΎΠ΄ΠΎΠ² ΠΊ Π΅Π³ΠΎ ΠΎΠΏΠΈΡΠ°Π½ΠΈΡ. Π ΡΠΎΠΊΡΡΠ΅ Π²Π½ΠΈΠΌΠ°Π½ΠΈΡ ΠΈΡΡΠ»Π΅Π΄ΠΎΠ²Π°ΡΠ΅Π»Π΅ΠΉ ΠΎΠΊΠ°Π·ΡΠ²Π°ΡΡΡΡ ΡΠ°Π·Π½ΠΎΡΡΠΎΠ²Π½Π΅Π²ΡΠ΅ ΠΏΡΠΎΡΠ²Π»Π΅Π½ΠΈΡ ΡΠ°ΠΌΠΎΠ΄Π΅ΡΠ΅ΡΠΌΠΈΠ½Π°ΡΠΈΠΈ: ΠΏΡΠΈΡΠΎΠ΄ΠΎΠΎΠ±ΡΡΠ»ΠΎΠ²Π»Π΅Π½Π½Π°Ρ ΡΠΏΠΎΡΠΎΠ±Π½ΠΎΡΡΡ ΠΊ ΡΠ°ΠΌΠΎΠΎΡΠ³Π°Π½ΠΈΠ·Π°ΡΠΈΠΈ ΠΈ Π²ΡΠΎΠΆΠ΄Π΅Π½Π½Π°Ρ ΠΏΠΎΡΡΠ΅Π±Π½ΠΎΡΡΡ ΠΈΠ½Π΄ΠΈΠ²ΠΈΠ΄Π° Π² Π°Π²ΡΠΎΠ½ΠΎΠΌΠΈΠΈ, ΠΏΡΠΎΡΠ΅ΡΡΡ ΡΠ°ΠΌΠΎΡΠ΅Π³ΡΠ»ΡΡΠΈΠΈ ΡΡΠ±ΡΠ΅ΠΊΡΠΎΠΌ ΠΏΠΎΠ²Π΅Π΄Π΅Π½ΠΈΡ ΠΈ Π΄Π΅ΡΡΠ΅Π»ΡΠ½ΠΎΡΡΠΈ, ΠΌΠ΅Ρ
Π°Π½ΠΈΠ·ΠΌΡ ΡΡΠ°Π½ΠΎΠ²Π»Π΅Π½ΠΈΡ ΡΡΠ±ΡΠ΅ΠΊΡΠ½ΠΎΡΡΠΈ ΠΈ ΡΠ°Π·Π²ΠΈΡΠΈΡ Π―, Π° ΡΠ°ΠΊΠΆΠ΅ ΡΠΏΠΎΡΠΎΠ±Ρ ΡΠ΅Π°Π»ΠΈΠ·Π°ΡΠΈΠΈ ΡΠ²ΠΎΠ±ΠΎΠ΄Ρ ΠΈ ΠΈΠ½ΡΠ΅Π½ΡΠΈΠΎΠ½Π°Π»ΡΠ½ΠΎΡΡΠΈ Π»ΠΈΡΠ½ΠΎΡΡΠΈ. ΠΠ°ΡΡΠ΄Ρ Ρ ΡΠΈΡΠΎΠΊΠΈΠΌ ΡΠ°Π·Π½ΠΎΠΎΠ±ΡΠ°Π·ΠΈΠ΅ΠΌ ΡΠ΅ΠΎΡΠΈΠΉ ΠΈ ΠΊΠΎΠ½ΡΠ΅ΠΏΡΠΈΠΉ ΠΎΡΠΌΠ΅ΡΠ°Π΅ΡΡΡ Π΄Π΅ΡΠΈΡΠΈΡ ΡΠΈΡΡΠ΅ΠΌΠ½ΡΡ
ΠΈ ΠΊΠΎΠΌΠΏΠ»Π΅ΠΊΡΠ½ΡΡ
ΠΌΠΎΠ΄Π΅Π»Π΅ΠΉ. Π Π΅Π·ΡΠ»ΡΡΠ°ΡΡ. ΠΠ²ΡΠΎΡΠ°ΠΌΠΈ Π²ΠΏΠ΅ΡΠ²ΡΠ΅ ΠΏΡΠ΅Π΄Π»ΠΎΠΆΠ΅Π½Π° ΠΊΠΎΠΌΠΏΠ»Π΅ΠΌΠ΅Π½ΡΠ°ΡΠ½Π°Ρ ΠΌΠΎΠ΄Π΅Π»Ρ ΡΠ°ΠΌΠΎΠ΄Π΅ΡΠ΅ΡΠΌΠΈΠ½Π°ΡΠΈΠΈ, ΠΏΠΎΠ·Π²ΠΎΠ»ΡΡΡΠ°Ρ ΠΈΠ½ΡΠ΅Π³ΡΠΈΡΠΎΠ²Π°ΡΡ ΠΈΠΌΠ΅ΡΡΠΈΠ΅ΡΡ ΡΠ΅ΠΎΡΠ΅ΡΠΈΡΠ΅ΡΠΊΠΈΠ΅ ΠΏΠΎΠ΄Ρ
ΠΎΠ΄Ρ ΠΊ ΠΈΡΡΠ»Π΅Π΄ΠΎΠ²Π°Π½ΠΈΡ Π·Π° ΡΡΠ΅Ρ ΡΡΠΎΠ²Π½Π΅Π²ΠΎΠ³ΠΎ ΡΠ°ΡΡΠΌΠΎΡΡΠ΅Π½ΠΈΡ ΠΈΠ½Π΄ΠΈΠ²ΠΈΠ΄Π½ΡΡ
, ΡΡΠ±ΡΠ΅ΠΊΡΠ½ΡΡ
ΠΈ Π»ΠΈΡΠ½ΠΎΡΡΠ½ΡΡ
Ρ
Π°ΡΠ°ΠΊΡΠ΅ΡΠΈΡΡΠΈΠΊ. ΠΠ°Π·ΠΎΠ²ΡΠΉ ΡΡΠΎΠ²Π΅Π½Ρ ΡΠΏΠΎΠ½ΡΠ°Π½Π½ΠΎΠΉ (ΡΡΠ½ΠΊΡΠΈΠΎΠ½Π°Π»ΡΠ½ΠΎΠΉ), ΡΠ°ΠΌΠΎΠ΄Π΅ΡΠ΅ΡΠΌΠΈΠ½Π°ΡΠΈΠΈ ΡΠΎΠΎΡΠ²Π΅ΡΡΡΠ²ΡΠ΅Ρ ΠΏΡΠΈΠ½ΡΠΈΠΏΠ°ΠΌ ΡΠ°ΠΌΠΎΠΎΡΠ³Π°Π½ΠΈΠ·Π°ΡΠΈΠΈ ΡΠ»ΠΎΠΆΠ½ΡΡ
ΠΎΡΠΊΡΡΡΡΡ
Π½Π΅ΡΠ°Π²Π½ΠΎΠ²Π΅ΡΠ½ΡΡ
ΡΠΈΡΡΠ΅ΠΌ, ΠΎΠ±Π»Π°Π΄Π°ΡΡΠΈΡ
ΠΏΡΠΈΡΠΎΠ΄ΠΎΠΎΠ±ΡΡΠ»ΠΎΠ²Π»Π΅Π½Π½ΠΎΠΉ ΡΠΏΠΎΡΠΎΠ±Π½ΠΎΡΡΡΡ ΠΊ ΡΠ°ΠΌΠΎΠ΄Π΅ΡΠ΅ΡΠΌΠΈΠ½ΠΈΡΠΎΠ²Π°Π½Π½ΠΎΠΌΡ ΠΏΠΎΠ²Π΅Π΄Π΅Π½ΠΈΡ. ΠΡΠΎΡΠΎΠΉ ΡΡΠΎΠ²Π΅Π½Ρ ΡΠ΅Π»Π΅Π½Π°ΠΏΡΠ°Π²Π»Π΅Π½Π½ΠΎΠΉ ΠΈΠ»ΠΈ Β«Π΄Π΅ΡΡΠ΅Π»ΡΠ½ΠΎΡΡΠ½ΠΎΠΉΒ» ΡΠ°ΠΌΠΎΠ΄Π΅ΡΠ΅ΡΠΌΠΈΠ½Π°ΡΠΈΠΈ ΠΏΠΎΠΊΠ°Π·ΡΠ²Π°Π΅Ρ ΡΠΎΠ»Ρ ΡΠΎΠ·Π½Π°ΡΠ΅Π»ΡΠ½ΠΎΠ³ΠΎ ΠΏΠ»Π°Π½ΠΈΡΠΎΠ²Π°Π½ΠΈΡ, Π²ΠΎΠ»Π΅Π²ΠΎΠ³ΠΎ ΡΡΠΈΠ»ΠΈΡ ΠΈ ΠΎΡΠΎΠ·Π½Π°Π½Π½ΠΎΠ³ΠΎ Π²ΡΠ±ΠΎΡΠ° ΠΊΠ°ΠΊ ΠΈΠ½ΡΡΡΡΠΌΠ΅Π½ΡΠ° Π΄ΠΎΡΡΠΈΠΆΠ΅Π½ΠΈΡ ΡΠ΅Π»ΠΈ ΠΈ ΡΠ°ΠΌΠΎΡΠ΅Π³ΡΠ»ΡΡΠΈΠΈ ΡΡΠ±ΡΠ΅ΠΊΡΠ°. ΠΠ°ΠΊΠΎΠ½Π΅Ρ, ΡΡΠ΅ΡΠΈΠΉ, Π½Π°ΠΈΠ²ΡΡΡΠΈΠΉ ΡΡΠΎΠ²Π΅Π½Ρ ΡΠΌΡΡΠ»ΠΎΠ²ΠΎΠΉ ΡΠ°ΠΌΠΎΠ΄Π΅ΡΠ΅ΡΠΌΠΈΠ½Π°ΡΠΈΠΈ ΠΎΠΏΠΈΡΡΠ²Π°Π΅Ρ ΡΠ΅Π½Π½ΠΎΡΡΠ½ΡΡ ΠΈ Π½ΡΠ°Π²ΡΡΠ²Π΅Π½Π½ΡΡ ΡΠ°ΠΌΠΎΡΠ΅Π³ΡΠ»ΡΡΠΈΡ, ΡΠ²ΡΠ·Π°Π½Π½ΡΡ Ρ ΠΎΡΡΡΠ΅ΡΡΠ²Π»Π΅Π½ΠΈΠ΅ΠΌ ΡΠΌΡΡΠ»ΠΎΠ²ΡΡ
Π²ΡΠ±ΠΎΡΠΎΠ². ΠΠ±ΡΡΠΆΠ΄Π΅Π½ΠΈΠ΅ ΡΠ΅Π·ΡΠ»ΡΡΠ°ΡΠΎΠ². ΠΠ°Π½Π½ΠΎΠ΅ ΠΈΡΡΠ»Π΅Π΄ΠΎΠ²Π°Π½ΠΈΠ΅ ΠΏΡΠ΅Π΄ΡΡΠ°Π²Π»ΡΠ΅Ρ Π½ΠΎΠ²ΡΠΉ Π²Π·Π³Π»ΡΠ΄ Π½Π° Π½Π°ΡΡΠ½ΡΡ ΠΏΡΠΎΠ±Π»Π΅ΠΌΡ ΡΠ°ΠΌΠΎΠ΄Π΅ΡΠ΅ΡΠΌΠΈΠ½Π°ΡΠΈΠΈ Π»ΠΈΡΠ½ΠΎΡΡΠΈ. ΠΠΎΠΌΠΏΠ»Π΅ΠΌΠ΅Π½ΡΠ°ΡΠ½Π°Ρ ΠΌΠΎΠ΄Π΅Π»Ρ ΠΎΡΡΠ°ΠΆΠ°Π΅Ρ ΡΠ»ΠΎΠΆΠ½ΡΡ ΠΌΠ½ΠΎΠ³ΠΎΡΡΠΎΠ²Π½Π΅Π²ΡΡ ΡΠΈΡΡΠ΅ΠΌΡ ΡΠ°ΠΌΠΎΠ΄Π΅ΡΠ΅ΡΠΌΠΈΠ½Π°ΡΠΈΠΈ, ΡΠ²ΠΎΠ»ΡΡΠΈΡ Π΅Π΅ ΠΌΠ΅Ρ
Π°Π½ΠΈΠ·ΠΌΠΎΠ² Π² ΠΏΡΠΎΡΠ΅ΡΡΠ΅ ΠΎΠ½ΡΠΎΠ³Π΅Π½Π΅Π·Π° ΠΎΡ Π±Π°Π·ΠΎΠ²ΡΡ
ΠΏΡΠΈΡ
ΠΎΠ»ΠΎΠ³ΠΈΡΠ΅ΡΠΊΠΈΡ
ΠΏΠΎΡΡΠ΅Π±Π½ΠΎΡΡΠ΅ΠΉ ΠΈΠ½Π΄ΠΈΠ²ΠΈΠ΄Π° Π΄ΠΎ ΡΠ»ΠΎΠΆΠ½ΡΡ
ΠΏΡΠΎΡΠ΅ΡΡΠΎΠ² ΡΠΌΡΡΠ»ΠΎΠ²ΠΎΠ³ΠΎ ΡΠ°ΠΌΠΎΠΎΠΏΡΠ΅Π΄Π΅Π»Π΅Π½ΠΈΡ Π»ΠΈΡΠ½ΠΎΡΡΠΈ
Sputnik V Effectiveness against Hospitalization with COVID-19 during Omicron Dominance
Mass vaccination campaigns against COVID-19 affected more than 90% of the population in most developed countries. The new epidemiologic wave of COVID-19 has been ongoing since the end of 2021. It is caused by a virus variant B.1.1.529, also known as “Omicron” and its descendants. The effectiveness of major vaccines against Omicron is not known. The purpose of this study is to evaluate the efficacy of the Sputnik V vaccine. The main goal is to assess its protection against hospitalization in the period of Omicron dominance. We conducted our study based on a large clinical center in Moscow (Russia) where 1112 patients were included. We used the case-population method to perform the calculations. The data we obtained indicate that the Omicron variant causes at least 90% of infections in the studied cohort. The effectiveness of protection against hospitalization with COVID-19 in our study was 85.9% (95% CI 83.0–88.0%) for those who received more than one dose. It was 87.6% (95% CI 85.4–89.5%) and 97.0% (95% CI 95.9–97.8%) for those who received more than two or three doses. The effectiveness in cases of more severe forms was higher than for less severe ones. Thus, present study indicates the high protective efficacy of vaccination against hospitalization with COVID-19 in case of Omicron lineage
DataSheet_1_Estimation of anti-orthopoxvirus immunity in Moscow residents and potential risks of spreading Monkeypox virus.docx
WHO has declared the outbreak of monkeypox as a public health emergency of international concern. In less than three months, monkeypox was detected in more than 30 000 people and spread to more than 80 countries around the world. It is believed that the immunity formed to smallpox vaccine can protect from monkeypox infection with high efficiency. The widespread use of Vaccinia virus has not been carried out since the 1980s, which raises the question of the level of residual immunity among the population and the identification of groups requiring priority vaccination. We conducted a cross-sectional serological study of remaining immunity among Moscow residents. To do this, a collection of blood serum samples of age group over 30 years old was formed, an in-house ELISA test system was developed, and a virus neutralization protocol was set up. Serum samples were examined for the presence of IgG antibodies against Vaccinia virus (n=2908), as well as for the ability to neutralize plaque formation with a Vaccinia virus MNIIVP-10 strain (n=299). The results indicate the presence of neutralizing antibody titer of 1/20 or more in 33.3 to 53.2% of people older than 45 years. Among people 30-45 years old who probably have not been vaccinated, the proportion with virus neutralizing antibodies ranged from 3.2 to 6.7%. Despite the higher level of antibodies in age group older than 66 years, the proportion of positive samples in this group was slightly lower than in people aged 46-65 years. The results indicate the priority of vaccination in groups younger than 45, and possibly older than 66 years to ensure the protection of the population in case of spread of monkeypox among Moscow residents. The herd immunity level needed to stop the circulation of the virus should be at least 50.25 β 65.28%.</p